Dhampur Bio Organics Limited has informed the Exchange about Copy of Newspaper Publication
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics reported its Q1 FY26 results via newspaper publication. Total income from operations rose to ₹785.26 crore, up about 23% from ₹638.62 crore in the same quarter last year. However, the company slipped into a loss, posting a net loss after tax of ₹22 crore (consolidated) and ₹19.37 crore (standalone), compared to a small profit of ₹0.12 crore and ₹1.11 crore respectively in Q1 FY25. EPS turned negative at -₹3.31 versus ₹0.02 a year ago. The board approved the results on July 28, 2025. The company noted that sugar is a seasonal business and a single quarter may not reflect full-year performance. A ₹50 crore commercial paper is outstanding on BSE (rated Care A2+) and is due for repayment on August 12, 2025.
Despite healthy revenue growth, the swing to a quarterly loss is a negative signal for short-term sentiment, especially given the swing from a small profit last year. However, the company attributes the weak quarter to the seasonal nature of the sugar business, so investors will likely look at later quarters for a clearer picture. The upcoming ₹50 crore commercial paper repayment in August is a small near-term watchpoint but well-supported by the credit rating.